Can’t Get Any Respect!
Back when COX-2's were under fire, representatives of the drug industry lamented that they "can't get any repsect." You might have remembered this bit...
Peter Rost: Pharma’s Black Knight
In the movie "Monty Python and the Holy Grail," King Arthur, played by Graham Chapman, fights a duel with the Black Knight, played by...
eDetailing ROI Better than DTC?
I attended the recent seminar entitled "Are You Building Brands...Or Relationships?", which was hosted by Lathian Systems, Inc., a provider of eDetailing and other...
Patients Come First?
In new a new TV ad campaign costing $20 million, Merck proclaims a new slogan: "Merck. Where patients come first." (See the New York...
3rd Annual Forum on Anonymous Patient-Level Data
Featured Conference 3rd Annual Forum on Anonymous Patient-Level Data June 2 - 3, 2005 Philadelphia, PA ...
Transparency is the Word These Days
Instead of fancy, expensive ads or PR campaigns, why don't pharma companies interview a few employees and let us hear directly from them?
Pharma BloggoSphere Update
This is the first article in a continuing series that will keep you up-to-date on Blog topics from a variety of pharma-related Blogs created by individuals as well as pharma companies.
A Strategic Approach to CME: Obtaining a High Return on Education Investment
This article reviews Imedex's approach to developing CME programs.
Is an FDA Drug Risk Advisory System Needed? Survey Results
Preliminary results from The Drug Risk Survey, which posed questions about the FDA's proposed Drug Watch program as well as the Drug Risk Advisory System proposed independently.
Limbic Market Research: Plumbing the Subconscious Motivators of Physicians
Segmedica's methodology for delving 'behind the curtain' of verbal responses to reveal what truly motivates physicians.
